KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to -$4.5 million.

  • Medpace Holdings' Cash from Investing Activities rose 4084.9% to -$4.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$31.1 million, marking a year-over-year decrease of 1000.42%. This contributed to the annual value of -$31.1 million for FY2025, which is 1000.42% down from last year.
  • As of Q4 2025, Medpace Holdings' Cash from Investing Activities stood at -$4.5 million, which was up 4084.9% from -$10.7 million recorded in Q3 2025.
  • In the past 5 years, Medpace Holdings' Cash from Investing Activities registered a high of $2.5 million during Q1 2024, and its lowest value of -$12.8 million during Q2 2024.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$8.9 million (2021), whereas its average is -$8.2 million.
  • Per our database at Business Quant, Medpace Holdings' Cash from Investing Activities skyrocketed by 12662.32% in 2024 and then plummeted by 49474.31% in 2025.
  • Medpace Holdings' Cash from Investing Activities (Quarter) stood at -$9.1 million in 2021, then decreased by 1.14% to -$9.2 million in 2022, then rose by 13.26% to -$8.0 million in 2023, then increased by 5.44% to -$7.6 million in 2024, then skyrocketed by 40.85% to -$4.5 million in 2025.
  • Its Cash from Investing Activities stands at -$4.5 million for Q4 2025, versus -$10.7 million for Q3 2025 and -$6.0 million for Q2 2025.